| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/19/2004 | EP1418917A1 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 05/19/2004 | EP1418913A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 05/19/2004 | EP1418908A1 Compounds for eliminating and/or relieving anhedonia |
| 05/19/2004 | EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 05/19/2004 | EP1418903A2 Prostanoids augment ocular drug penetration |
| 05/19/2004 | EP1418896A2 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 05/19/2004 | EP1418893A1 Compositions and techniques for localized therapy of restenosis |
| 05/19/2004 | EP1418889A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 05/19/2004 | EP1418880A1 Oral rinse for treatment or prevention of bacterial and fungal infection |
| 05/19/2004 | EP1418864A1 Method and intra sclera implant for treatment of glaucoma and presbyopia |
| 05/19/2004 | EP1418861A2 Methods for treating prostatitis |
| 05/19/2004 | EP1267869B1 Metabotropic glutamate receptor antagonists for the treatment of tolerance and dependance |
| 05/19/2004 | EP1261357A4 Isolation and transplantation of retinal stem cells |
| 05/19/2004 | EP1163523B1 Method for detecting predisposition to a venous thromboembolic disease |
| 05/19/2004 | EP1128811B1 Drug delivery device, especially for the delivery of progestins and estrogens |
| 05/19/2004 | EP1017810B1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | EP0970372B1 Assay for disease related conformation of a protein |
| 05/19/2004 | EP0801572B1 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 05/19/2004 | EP0637237B1 Calcium receptor-active molecules |
| 05/19/2004 | EP0608433B1 Composition for dermatologic preparation |
| 05/19/2004 | DE20220838U1 Orale Arzneiform enthaltend einen therapeutischen Wirkstoff und ein Gegenwirkungsmittel Oral dosage form containing a therapeutic agent and a counteracting means |
| 05/19/2004 | DE202004004618U1 Composition containing bilberry extract, useful for treating headache and migraine, also contains antioxidants and micronutrients |
| 05/19/2004 | DE10251028A1 Verwendung von Progesteron oder einem Progesteronrezeptor-Agonisten zur Hemmung der Steroidsynthese Use of progesterone or a progesterone receptor agonists for the inhibition of steroid synthesis |
| 05/19/2004 | CN1498385A Methods and devices for quantitative analysis of x-ray images |
| 05/19/2004 | CN1498271A Potassium channel interactors protein and uses therefor |
| 05/19/2004 | CN1498224A Novel peptides as NS3-serine protease inhibitors of hepatitiscvirus |
| 05/19/2004 | CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 05/19/2004 | CN1498210A MCH antagonists and their use in treatment of obesity |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/19/2004 | CN1498115A Hydroxyalkyl starch-active agent-conjugate |
| 05/19/2004 | CN1498114A Pharmaceutical composition having reduced tendency for drug crystallization |
| 05/19/2004 | CN1498112A Combination therapy for estrogen-dependent disorders |
| 05/19/2004 | CN1498108A Nicotinic receptor agonists for treatment of inflammatory diseases |
| 05/19/2004 | CN1498107A Combination of taxane and cyclin-dependent kinase inhibitor |
| 05/19/2004 | CN1498105A Synergistic combinations of vitaminosis A receptor ligands and selected cytotoxic agents for treatment of cancer |
| 05/19/2004 | CN1498096A Condom with erectogenic composition |
| 05/19/2004 | CN1496736A Use of neuron sodium ion pass antagonist for controlling homothermal animal ectoparasite |
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150187C Use of selective antagonists of a1b-adrenergic receptor for improvement of sexual dysfunction |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/19/2004 | CN1150031C Use of histamine of therapeutic purposes |
| 05/19/2004 | CN1150002C Antitumor compsn. contg. synergistic compsn. of anthracycline derivative with camptothecin derivate |
| 05/19/2004 | CN1149992C Antimycotic gel with active substance release |
| 05/19/2004 | CN1149983C Compositions and methos for treatment of anorectal disorders |
| 05/19/2004 | CN1149977C Pharmaceutical compositions in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 05/18/2004 | US6737441 Preventing or treating persistent chronic gastritis, ulcers and/or stomach cancer |
| 05/18/2004 | US6737437 EP4 receptor selective agonists in the treatment of osteoporosis |
| 05/18/2004 | US6737427 Administering to the patient suffering with the disease caused by overproduction of mucin such as chronic obstructive pulmonary diseases including asthma, emphysema, and chronic bronchitis a mucin glycoprotein synthesis inhibitor |
| 05/18/2004 | US6737397 Control of cancer growth through the interaction of [MET5]-enkephalin and the zeta receptor |
| 05/18/2004 | US6737085 Naturally derived antidepressant composition in the form of a food, dietary supplement, medicine or the like that contains neither hypericin nor hyperforin and is safer even during extended administration, for therapy of depression |
| 05/18/2004 | US6737080 Laminate comprising first moisture sensitive layer including moisture sensitive component, and second moisture absorbing layer including activated desiccant; spatial separation of layers prevents components from moving between layers |
| 05/18/2004 | US6737062 Immunogenic compositions |
| 05/18/2004 | US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
| 05/18/2004 | CA2301794C Improved enriched platelet wound healant |
| 05/13/2004 | WO2004039412A2 Compositions for cancer treatment |
| 05/13/2004 | WO2004039409A2 Composition comprising activators of ik potassium channels and calcineurin antagonists and use thereof |
| 05/13/2004 | WO2004039408A1 Medicinal composition |
| 05/13/2004 | WO2004039395A1 Immunnoevasive agent for preventing graft rejection |
| 05/13/2004 | WO2004039390A1 Ointment composition for treating decubitus ulcers and methods for its making and its use |
| 05/13/2004 | WO2004039371A2 Compositions of cyclooxygenase-2 selective inhibitors and nmda receptor antagonists for the treatment or prevention of neuropathic pain |
| 05/13/2004 | WO2004039360A1 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 05/13/2004 | WO2004039355A1 Therapeutic compositions |
| 05/13/2004 | WO2004039336A2 Use of thiol-based compositions in treating chemotherapeutic agent-induced thrombocytopenia |
| 05/13/2004 | WO2004039325A2 Treatment of pain with jnk inhibitors |
| 05/13/2004 | WO2004039322A2 Novel combination therapy for schizophrenia focused on improved cognition: 5-ht-2a/d2 blockade with adjunctive blockade of prefrontal da reuptake |
| 05/13/2004 | WO2004039321A2 Combinative nicotinic/d1 agonism therapy for the treatment of alzheimer’s disease |
| 05/13/2004 | WO2004039313A2 Preventing desensitization of receptors |
| 05/13/2004 | WO2004039311A2 Human vps4a and vps4b functions in viral budding |
| 05/13/2004 | WO2004039148A1 Nonbacterial prostatitis model animal |
| 05/13/2004 | WO2004009542A3 Process for preparing certain pyrrolotriazine compounds |
| 05/13/2004 | WO2004006931A3 Pharmaceutical compostions comprising an allosteric carboxylic inhibitor of matrix metalloproteinase-13 and a selective inhibitor of cyclooxygenase-2 |
| 05/13/2004 | WO2004002461A3 Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
| 05/13/2004 | WO2004000293A3 Use of taurine or derivatives thereof for the treatment of alopecia |
| 05/13/2004 | WO2004000045A3 Liquid compositions comprising non-digestible oligosaccharides and green tea catechins, method and uses thereof |
| 05/13/2004 | WO2003101389A3 Relief of aids symptoms |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003094888A9 Processes for forming a drug delivery device |
| 05/13/2004 | WO2003082207A3 Volume efficient controlled release dosage form |
| 05/13/2004 | WO2003080022A3 Analgesics for nasal administration |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003053921A9 Mutant proteinase inhibitors and uses thereof |
| 05/13/2004 | WO2003051454A3 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 05/13/2004 | WO2003045977A3 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes |
| 05/13/2004 | WO2003039475A8 Methods of identifying and using modulators of fractalkine receptor |
| 05/13/2004 | WO2003037291A8 Cream for treatment of skin injured by the sun |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | WO2003020208A3 Treatment of neurologic hemorrhage |
| 05/13/2004 | WO2003018595A3 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/13/2004 | WO2003006652A3 Inhibition of specific histone deacetylase isoforms |
| 05/13/2004 | WO2002062367A8 Medical composition for managing hormone balance |
| 05/13/2004 | WO2002034272A3 Methods of improving central nervous system functioning |
| 05/13/2004 | US20040093627 Methods |
| 05/13/2004 | US20040093626 Screening modulators of g-protein couple receptors to identify appetite control agent for treatment of physiological eating disorders and obesity |
| 05/13/2004 | US20040092745 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092714 Comprises osteoclast associated receptors (OSCAR) for the identifying modulators for treatment of bone disorders |
| 05/13/2004 | US20040092603 Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties |
| 05/13/2004 | US20040092602 Method for treatment and chemoprevention of prostate cancer |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |